Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice
Journal of Clinical Medicine · 17.09.2023 · 12 (18) · 6017
DOI: 10.3390/jcm12186017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.09.2023. Verfasst von Elisa Gremese und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Immunology Unit, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Catholic University of the Sacred Heart, 00168 Roma, Italy. Die Arbeit wurde bisher 172-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Serum albumin (ALB), one of the most important proteins in human physiology, has the main functions of maintaining plasma oncotic pressure and plasma volume, transporting hormones, vitamins, oligominerals and drugs, and exerting a powerful antioxidant-anti-inflammatory role. Its prognostic value in liver and malabsorption syndromes is well known. In this narrative review, an analysis of the most important studies evaluating the prognostic significance of low serum ALB levels in hospitalized patients was performed. Specifically, the risk in emergency medicine, cardiovascular diseases, Coronavirus Disease 19 (COVID-19) infection, nephrology, oncology, and autoimmune rheumatic diseases has been examined to fully explore its clinical value. ALB is a negative acute-phase reactant and the reduction in its serum levels represents a threatening parameter for long-term survival in several clinical settings, and a strong biomarker for a poor prognosis in most diseases. Therefore, clinicians should consider serum ALB as a valuable tool to assess the efficacy of specific therapies, both in hospitalized patients and in chronic follow-up.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Immunology Unit, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Catholic University of the Sacred Heart, 00168 Roma, Italy.
- Immunology Core Facility, Fondazione Policlinico Universitario A. Gemelli-IRCCS, 00168 Roma, Italy.
- Clinical Immunology Unit, Fondazione Policlinico Universitario A. Gemelli-IRCCS, 00168, Roma, Italy.
- Rheumatology Division, Fondazione Policlinico Universitario A. Gemelli-IRCCS, 00168 Roma, Italy.
- Department of Internal Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy.
ORCID-Profile: Elisa Gremese, Dario Bruno, Simone Perniola
Zitieren
APA
Gremese, E., Bruno, D., Varriano, V., Perniola, S., Petricca, L., & Ferraccioli, G. (2023). Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice. Journal of Clinical Medicine, 12(18), 6017. https://doi.org/10.3390/jcm12186017
Vancouver
Gremese E, Bruno D, Varriano V, Perniola S, Petricca L, Ferraccioli G. Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice. Journal of Clinical Medicine. 2023;12(18):6017. doi:10.3390/jcm12186017
BibTeX
@article{Gremese2023,
author = {Gremese, Elisa and Bruno, Dario and Varriano, Valentina and Perniola, Simone and Petricca, Luca and Ferraccioli, Gianfranco},
title = {Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {18},
pages = {6017},
doi = {10.3390/jcm12186017}
}
EUVIMED